Literature DB >> 11325861

Epithelial-stromal interactions and tumor progression: meeting summary and future directions.

L M Matrisian1, G R Cunha, S Mohla.   

Abstract

The Epithelial-Stromal Interactions Workshop was organized with the purpose of accelerating progress in understanding the interrelationship between tumor cells and their microenvironment and applying this knowledge to the control of tumor progression. The format of the meeting was the presentation of brief reports that focused on concepts rather than specifics, with extensive discussion periods to identify the issues and barriers hindering progress in this area. This report summarizes the findings of this meeting, highlighting the intimate relationship between tumor cells and their environment and addressing the opportunities that manipulation of host-tumor interactions has for therapeutic intervention. Several specific recommendations are made to advance knowledge and progress in this field.

Entities:  

Mesh:

Year:  2001        PMID: 11325861

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Signaling through estrogen receptors modulates telomerase activity in human prostate cancer.

Authors:  Simona Nanni; Michela Narducci; Linda Della Pietra; Fabiola Moretti; Annalisa Grasselli; Piero De Carli; Ada Sacchi; Alfredo Pontecorvi; Antonella Farsetti
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  A novel 3-dimensional culture system as an in vitro model for studying oral cancer cell invasion.

Authors:  Hai S Duong; Anh D Le; Qunzhou Zhang; Diana V Messadi
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

Review 3.  Gene targeting to the stroma of the prostate and bone.

Authors:  Roger S Jackson; Omar E Franco; Neil A Bhowmick
Journal:  Differentiation       Date:  2008-05-20       Impact factor: 3.880

4.  Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression.

Authors:  Jan Friederichs; Robert Rosenberg; Joerg Mages; Klaus-Peter Janssen; Christian Maeckl; Hjalmar Nekarda; Bernhard Holzmann; Joerg-Ruediger Siewert
Journal:  Int J Colorectal Dis       Date:  2005-05-10       Impact factor: 2.571

5.  Analysis of gene expression in human colorectal cancer tissues by cDNA array.

Authors:  Hiroyuki Yamamoto; Arisa Imsumran; Hiroshi Fukushima; Yasushi Adachi; Yongfen Min; Shouhei Iku; Shina Horiuchi; Mio Yoshida; Kazuko Shimada; Shigeru Sasaki; Fumio Itoh; Takao Endo; Kohzoh Imai
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

6.  Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer.

Authors:  Antonia Wenners; Felix Hartmann; Arne Jochens; Anna Maria Roemer; Ibrahim Alkatout; Wolfram Klapper; Marion van Mackelenbergh; Christoph Mundhenke; Walter Jonat; Maret Bauer
Journal:  Int J Clin Oncol       Date:  2015-11-14       Impact factor: 3.402

7.  Paracrine communication between malignant and non-malignant prostate epithelial cells in culture alters growth rate, matrix protease secretion and in vitro invasion.

Authors:  Andrea H Greiff; William M Fischer; Inder Sehgal
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 8.  Deciphering the molecular basis of breast cancer metastasis with mouse models.

Authors:  Ann E Vernon; Suzanne J Bakewell; Lewis A Chodosh
Journal:  Rev Endocr Metab Disord       Date:  2007-09       Impact factor: 6.514

9.  Molecular signatures of metastasis in head and neck cancer.

Authors:  Stefano Colella; Kristy L Richards; Linda L Bachinski; Keith A Baggerly; Spiridon Tsavachidis; James C Lang; David E Schuller; Ralf Krahe
Journal:  Head Neck       Date:  2008-10       Impact factor: 3.147

10.  Gene expression profiling of breast cancers with emphasis of beta-catenin regulation.

Authors:  Mee Sook Roh; Sook Hee Hong; Jin Sook Jeong; Hyuk Chan Kwon; Min Chan Kim; Se Heon Cho; Jin Han Yoon; Tae Ho Hwang
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.